Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

Schneider BJ, Naidoo J, Santomasso BD, Lacchetti C, Adkins S, Anadkat M, Atkins MB, Brassil KJ, Caterino JM, Chau I, Davies MJ, Ernstoff MS, Fecher L, Ghosh M, Jaiyesimi I, Mammen JS, Naing A, Nastoupil LJ, Phillips T, Porter LD, Reichner CA, Seigel C, Song JM, Spira A, Suarez-Almazor M, Swami U, Thompson JA, Vikas P, Wang Y, Weber JS, Funchain P, Bollin K

Open source

DOI: 10.1200/jco.21.01440
Published: 2021 Dec 20
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.21.01440,
  title = {Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.},
  author = {Schneider BJ and Naidoo J and Santomasso BD and Lacchetti C and Adkins S and Anadkat M and Atkins MB and Brassil KJ and Caterino JM and Chau I and Davies MJ and Ernstoff MS and Fecher L and Ghosh M and Jaiyesimi I and Mammen JS and Naing A and Nastoupil LJ and Phillips T and Porter LD and Reichner CA and Seigel C and Song JM and Spira A and Suarez-Almazor M and Swami U and Thompson JA and Vikas P and Wang Y and Weber JS and Funchain P and Bollin K},
  year = {2021},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.21.01440},
  url = {https://doi.org/10.1200/jco.21.01440}
}

RIS

TY  - JOUR
TI  - Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
AU  - Schneider BJ
AU  - Naidoo J
AU  - Santomasso BD
AU  - Lacchetti C
AU  - Adkins S
AU  - Anadkat M
AU  - Atkins MB
AU  - Brassil KJ
AU  - Caterino JM
AU  - Chau I
AU  - Davies MJ
AU  - Ernstoff MS
AU  - Fecher L
AU  - Ghosh M
AU  - Jaiyesimi I
AU  - Mammen JS
AU  - Naing A
AU  - Nastoupil LJ
AU  - Phillips T
AU  - Porter LD
AU  - Reichner CA
AU  - Seigel C
AU  - Song JM
AU  - Spira A
AU  - Suarez-Almazor M
AU  - Swami U
AU  - Thompson JA
AU  - Vikas P
AU  - Wang Y
AU  - Weber JS
AU  - Funchain P
AU  - Bollin K
PY  - 2021
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.21.01440
UR  - https://doi.org/10.1200/jco.21.01440
ER  -

APA

BJ, S., J, N., BD, S., C, L., S, A., M, A., MB, A., KJ, B., JM, C., I, C., MJ, D., MS, E., L, F., M, G., I, J., JS, M., A, N., LJ, N., T, P., LD, P., CA, R., C, S., JM, S., A, S., M, S., U, S., JA, T., P, V., Y, W., JS, W., P, F., & K, B. (2021). Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.21.01440

Source records

pubmed · retrieved 2026-09-25T22:37:39.676Z